We are live on ! Find out more
IVA

Inventiva
IVA

53 hedge funds and large institutions have $217M invested in Inventiva in 2025 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

638% more capital invested

Capital invested by funds: $29.4M → $217M (+$188M)

500% more funds holding in top 10

Funds holding in top 10: 1 → 6 (+5)

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

253% more funds holding

Funds holding: 15 → 53 (+38)

20.78% more ownership

Funds ownership: 3.67% → 24.45% (+21%)

Holders
53
Holders Change
+38
Holders Change %
+253.33%
% of All Funds
0.64%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.07%
New
38
Increased
6
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SB
Samsara BioCapital
California
+$24.1M
2
PBA
Paradigm Biocapital Advisors
New York
+$18.6M
3
ACM
ADAR1 Capital Management
Texas
+$12.6M
4
UBS Group
UBS Group
Switzerland
+$12.2M
5
Millennium Management
Millennium Management
New York
+$11.8M

Top Sellers

Rank Fund Capital Flow
1
YCM
Yiheng Capital Management
California
-$11.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
SB
1
Samsara BioCapital
California
$24.2M +$24.1M +5,194,805 New
PBA
2
Paradigm Biocapital Advisors
New York
$18.6M +$18.6M +4,000,000 New
ACM
3
ADAR1 Capital Management
Texas
$12.6M +$12.6M +2,709,846 New
TECP
4
Trails Edge Capital Partners
Georgia
$12.4M +$12.4M +2,657,997 New
Millennium Management
5
Millennium Management
New York
$12.3M +$11.8M +2,540,540 +2,268%
UBS Group
6
UBS Group
Switzerland
$12.3M +$12.2M +2,634,580 +28,882%
SCP
7
SymBiosis Capital Partners
Arkansas
$12.1M +$12.1M +2,600,000 New
Franklin Resources
8
Franklin Resources
California
$11.6M +$11.6M +2,500,141 New
CP
9
Caligan Partners
New York
$9.3M +$9.29M +2,000,000 New
PCH
10
Polar Capital Holdings
United Kingdom
$9.29M +$9.29M +1,998,880 New
AP
11
Andera Partners
$8.45M +$8.45M +1,818,181 New
ABG
12
Ally Bridge Group
New York
$6.97M +$6.97M +1,500,000 New
YF
13
Yu Fan
$6.97M +$6.97M +1,500,000 New
NMC
14
NEA Management Company
Maryland
$6.8M – – –
NCM
15
NEXTBio Capital Management
California
$6.04M +$6.03M +1,298,701 New
RI
16
RTW Investments
New York
$6.04M +$6.03M +1,298,701 New
PBM
17
Propel Bio Management
California
$4.65M +$4.65M +1,000,000 New
BI
18
BVF Inc
California
$3.19M – – –
BFM
19
Boothbay Fund Management
New York
$3.06M +$3.06M +658,971 New
Ameriprise
20
Ameriprise
Minnesota
$2.86M +$2.86M +615,473 New
JGC
21
J. Goldman & Co
New York
$2.4M +$2.4M +516,445 New
Morgan Stanley
22
Morgan Stanley
New York
$2.36M +$2.22M +477,921 +1,605%
IC
23
Ikarian Capital
Texas
$2.33M +$2.34M +502,601 New
Alyeska Investment Group
24
Alyeska Investment Group
Illinois
$2.33M +$2.32M +500,000 New
DTC
25
Deep Track Capital
Connecticut
$2.28M +$2.28M +490,000 New
1
2 3

IVA Hedge Fund Activity: Q4 2025 in Review

53 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Inventiva (IVA) for Q4 2025, worth a combined $217M — up 638% from $29.4M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new IVA positions and 0 closed out — a net gain of 38 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Samsara BioCapital, opening a new position worth an estimated $24.1M. The largest seller was Yiheng Capital Management, cutting an estimated $11.1M.

  • 53 institutional investors held Inventiva (IVA) as of Q4 2025, up from 15 in Q3 2025.
  • Funds reported $217M of Inventiva stock for Q4 2025, up 638% quarter-over-quarter.
  • 38 funds opened new Inventiva positions in Q4 2025 and 0 closed out, a net change of +38 holders.
  • The largest Inventiva buyer in Q4 2025 was Samsara BioCapital, an estimated $24.1M added.
  • The largest Inventiva seller in Q4 2025 was Yiheng Capital Management, an estimated $11.1M sold.

Based on aggregated 13F filings for Q4 2025.